Study to the effect of Phaltrikadi yoga in Medoroga (Dyslipidemia).

A clinical study to determine the efficacy of Phaltrikadi yoga in the management of Medoroga with special reference to Dyslipidemia - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072787

Enrollment

Registered

2024-08-20

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E789- Disorder of lipoprotein metabolism, unspecified Health Condition 2: E789- Disorder of lipoprotein metabolism, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient with serum lipid level .serum cholesterol -200-350 mg/dl .serum triglycerides -150-350 mg/dl .serum LDL -100-200 mg/dl .serum VLDL -30-100 mg/dl .serum HDL -20-40 mg/dl Patient willing to participate in the trial patient between the age group of 30-70 years of eiter gender will be selected for the study.

Exclusion criteria

Exclusion criteria: Patient having illness like carcinoma, renal and liver disorders. Patient having past history of myocardial infraction, unstable angina and congestive cardiac failure and cerebrovascular accident. Pregnant females and lactating mother.

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of Phaltrikadi Yoga in the management of Medoroga with special reference to Dyslipidemia.Timepoint: 12 weeks	—

Secondary

Measure	Time frame
To assess the clinical safety of Phaltrikadi Yoga in patient of Medoroga with special reference to Dyslipedemia.Timepoint: 12 weeks	—

Countries

India

Contacts

Public ContactRamesh Acharya

Rajiv Gandhi Ayurvedic College and Hospital

drmsony@gmail.com8219121014

Outcome results